Pandect Bioventures, L.P. — Form D/A
Pandect Bioventures, L.P. of SOUTH SAN FRANCISCO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2020-11-23. The offering totals $100.0M, of which $33.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-11-23
- Form: D/A
- Accession: 0001757884-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $100.0M
- Amount sold: $33.0M
- Remaining: $67.0M
- Investors: 2
- Date of first sale: 2018-11-14
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-325620
Issuer
- Name: Pandect Bioventures, L.P.
- CIK: 0001757884
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 280 UTAH AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-410-5000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael NA Hui | Director | South San Francisco, CA |
| Walter NA Moos | Director | South San Francisco, CA |
| N/A NA Pandect Bioventures GP, LLC | Director | South San Francisco, CA |
| Mohamad NA Tabrizi | Director | South San Francisco, CA |
Other filings by this issuer (1)
More